Your browser doesn't support javascript.
loading
Myocardial functional changes in transfemoral versus transapical aortic valve replacement.
Asthana, Niraj; Mantha, Aditya; Yang, Eric H; Suh, William; Aksoy, Olcay; Shemin, Richard J; Vorobiof, Gabriel; Benharash, Peyman.
Afiliação
  • Asthana N; Division of Cardiac Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Mantha A; Division of Cardiac Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Yang EH; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Suh W; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Aksoy O; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Shemin RJ; Division of Cardiac Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Vorobiof G; Division of Cardiology, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California.
  • Benharash P; Division of Cardiac Surgery, David Geffen School of Medicine, University of California Los Angeles, Los Angeles, California. Electronic address: pbenharash@mednet.ucla.edu.
J Surg Res ; 221: 304-310, 2018 01.
Article em En | MEDLINE | ID: mdl-29229143
ABSTRACT

BACKGROUND:

Transcatheter aortic valve replacement (TAVR) has greatly expanded the treatment options available for patients with severe aortic stenosis at high surgical risk. MATERIALS AND

METHODS:

We compared changes in myocardial function in TAVR with a transfemoral (TF) versus a transapical (TA) approach at a major tertiary hospital from 2012-2016. Traditional echocardiographic measures of cardiac structure and function were tracked, alongside the use of two-dimensional speckle tracking echocardiography to measure myocardial strain and strain rates.

RESULTS:

For the entire cohort with complete data at all time points (n = 42), between the pre-TAVR baseline (mean 20.1 d) and the post-TAVR 1-mo follow-up (mean 32.7 d), global longitudinal strain significantly increased (from -15.6% to -18.2%, P < 0.001). When comparing the TF (n = 31) and TA (n = 11) groups, TA patients showed persistently impaired apical longitudinal strain at the 1-mo follow-up (-15.9% versus -22.3%, P < 0.05). In terms of clinical outcomes, both groups (n = 131 for TF, n = 53 for TA) were similar in terms of 30-d mortality, readmission rate, and risk of post-TAVR acute kidney injury. However, TA patients experienced significantly longer length of hospitalization (7.58 versus 3.92 d, P = 0.02), intensive care unit hours (105.4 versus 47.1 h, P = 0.02), and were at a greater risk of long-term (>72 h) intensive care unit stay (45% versus 25%, P = 0.01).

CONCLUSIONS:

Patients undergoing TA-TAVR exhibit impaired apical longitudinal strain, although global myocardial function is similar to TF-TAVR otherwise. Myocardial strain measured by two-dimensional speckle tracking echocardiography appears to be a sensitive method to detect subtle cardiac remodeling after TAVR.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substituição da Valva Aórtica Transcateter / Coração Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Substituição da Valva Aórtica Transcateter / Coração Tipo de estudo: Observational_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2018 Tipo de documento: Article